COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia

Alessandro Bertolino, Grazia Caforio, Giuseppe Blasi, Antonio Rampino, Lorenzo Sinibaldi, Sophia Douzgou, Marcello Nardini, Daniel R. Weinberger, Bruno Dallapiccola

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'COMT Val<sup>158</sup>Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia'. Together they form a unique fingerprint.